InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
T+90 hit rate
50%
T+90 mean return
-15.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Flynn Paul R, Vice-Président Exécutif, Revenus Mondiaux. Insider active across 1 company, notably DEXCOM INC. Aggregated, 10 filings have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €2m. History available since 9 September 2021. The latest transaction was disclosed on 18 December 2023 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
3,163 shares@ US$121.850311.9% of flowCommon StockSEC:0001093557-23-000256:0
2,781 shares@ US$120.0010.3% of flowCommon StockSEC:0001093557-23-000104:0
5,478 shares@ US$111.39919.4% of flowCommon StockSEC:0001093557-23-000078:0
18,776 shares@ US$0.0010.0% of flowCommon StockSEC:0001093557-23-000056:0
8,988 shares@ US$123.5035.5% of flowCommon StockSEC:0001093557-22-000181:0
5,297 shares@ US$0.0010.0000% mcap0.0% of flowCommon StockSEC:0001093557-22-000048:0
2,925 shares@ US$0.0010.0% of flowCommon StockSEC:0001093557-21-000290
2,925 shares@ US$0.0010.0000% mcap0.0% of flowCommon StockSEC:0001093557-21-000290:0
743 shares@ US$541.360.0013% mcap50.0% of flowCommon StockSEC:0001093557-21-000213:0
743 shares@ US$541.3611.4% of flowCommon StockSEC:0001093557-21-000213
10 of 10 declarations
About Flynn Paul R
Paul R. Flynn serves as Executive Vice President, Global Revenue at Dexcom Inc. In this role, he is responsible for the global revenue strategy for the company, which specializes in blood glucose monitoring technologies. Paul plays a key role in optimizing sales and developing new market opportunities. His expertise is essential for Dexcom's growth.
